Palisade Bio Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.9% | -2.3% | -14.3% | -35.8% | -22.6% | -97.9% | -33.3% | +50.0% | +33.3% | -25.0% | +0.0% | |
| – | -31.7% | +16.7% | -48.6% | -38.4% | +205.0% | -39.4% | -6.1% | -45.4% | -39.5% | +4.5% | +506.6% | |
| – | – | – | – | – | +108.1% | +6.4% | +381.7% | – | – | – | – | |
| – | -117.6% | – | -242.5% | – | – | +1,047.0% | -299.1% | – | -68.0% | +247.8% | +17.8% | |
| – | -56.2% | -33.9% | -41.6% | -98.2% | +250.1% | +0.0% | -100.0% | – | -60.0% | -100.0% | – | |
| – | – | -67.5% | -104.0% | – | -21.5% | -100.2% | +800.0% | -81.5% | -60.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -68.9% | -79.1% | +258.5% | +124.3% | -100.7% | – | – | -35.3% | +72.7% | |
| – | – | – | – | – | -116.2% | – | -109.3% | +331.7% | -50.5% | +9.0% | -24.9% | |
| – | -83.1% | +510.7% | -79.0% | -63.6% | +263.2% | -71.3% | +1,202.1% | -38.0% | -26.7% | -14.3% | +1,303.0% | |
| – | – | – | -181.3% | – | – | – | – | -80.7% | -97.4% | -5,428.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.